DiaMedica Historical Income Statement

DMAC Stock  USD 2.65  0.07  2.57%   
Historical analysis of DiaMedica Therapeutics income statement accounts such as Total Revenue of 0.0 or Other Operating Expenses of 22.3 M can show how well DiaMedica Therapeutics performed in making a profits. Evaluating DiaMedica Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DiaMedica Therapeutics's future profits or losses.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining DiaMedica Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DiaMedica Therapeutics is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.

About DiaMedica Income Statement Analysis

DiaMedica Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DiaMedica Therapeutics shareholders. The income statement also shows DiaMedica investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

DiaMedica Therapeutics Income Statement Chart

DiaMedica Therapeutics Income Statement is one of the three primary financial statements used for reporting DiaMedica's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of DiaMedica Therapeutics revenue and expense. DiaMedica Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, DiaMedica Therapeutics' Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 13.8 M, whereas Depreciation And Amortization is forecasted to decline to about 28.5 K.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of DiaMedica Therapeutics. It is also known as DiaMedica Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from DiaMedica Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DiaMedica Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.At present, DiaMedica Therapeutics' Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 13.8 M, whereas Depreciation And Amortization is forecasted to decline to about 28.5 K.
 2023 2024 (projected)
Reconciled Depreciation28K21.7K
Interest Income44.9K47.1K

DiaMedica Therapeutics income statement Correlations

-0.33-0.13-0.040.030.02-0.170.15-0.040.0-0.20.0-0.45-0.150.45-0.15-0.42-0.37-0.340.2
-0.33-0.30.85-0.84-0.850.85-0.880.85-0.830.85-0.830.210.91-0.870.110.590.750.8-0.74
-0.13-0.3-0.240.220.26-0.190.24-0.240.25-0.290.250.58-0.170.160.840.150.15-0.040.16
-0.040.85-0.24-1.0-1.00.98-0.991.0-0.990.81-0.990.10.98-0.870.180.640.80.83-0.73
0.03-0.840.22-1.01.0-0.980.99-1.01.0-0.791.0-0.1-0.980.88-0.2-0.67-0.82-0.860.68
0.02-0.850.26-1.01.0-0.980.99-1.01.0-0.81.0-0.07-0.970.87-0.16-0.65-0.8-0.850.68
-0.170.85-0.190.98-0.98-0.98-0.990.98-0.970.83-0.970.170.97-0.920.220.730.860.87-0.73
0.15-0.880.24-0.990.990.99-0.99-0.990.99-0.820.99-0.13-0.980.92-0.18-0.7-0.84-0.880.7
-0.040.85-0.241.0-1.0-1.00.98-0.99-0.990.81-0.990.10.98-0.870.180.640.80.83-0.73
0.0-0.830.25-0.991.01.0-0.970.99-0.99-0.761.0-0.06-0.970.86-0.17-0.66-0.8-0.850.65
-0.20.85-0.290.81-0.79-0.80.83-0.820.81-0.76-0.760.210.82-0.760.090.480.640.65-0.88
0.0-0.830.25-0.991.01.0-0.970.99-0.991.0-0.76-0.06-0.970.87-0.17-0.66-0.8-0.850.65
-0.450.210.580.1-0.1-0.070.17-0.130.1-0.060.21-0.060.2-0.270.740.210.410.33-0.24
-0.150.91-0.170.98-0.98-0.970.97-0.980.98-0.970.82-0.970.2-0.90.250.70.850.88-0.74
0.45-0.870.16-0.870.880.87-0.920.92-0.870.86-0.760.87-0.27-0.9-0.23-0.83-0.92-0.950.6
-0.150.110.840.18-0.2-0.160.22-0.180.18-0.170.09-0.170.740.25-0.230.320.50.37-0.13
-0.420.590.150.64-0.67-0.650.73-0.70.64-0.660.48-0.660.210.7-0.830.320.910.84-0.34
-0.370.750.150.8-0.82-0.80.86-0.840.8-0.80.64-0.80.410.85-0.920.50.910.96-0.49
-0.340.8-0.040.83-0.86-0.850.87-0.880.83-0.850.65-0.850.330.88-0.950.370.840.96-0.44
0.2-0.740.16-0.730.680.68-0.730.7-0.730.65-0.880.65-0.24-0.740.6-0.13-0.34-0.49-0.44
Click cells to compare fundamentals

DiaMedica Therapeutics Account Relationship Matchups

DiaMedica Therapeutics income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization877K226K24K25K30K28.5K
Interest Expense119K229K82K353K406.0K426.2K
Other Operating Expenses10.7M12.5M13.6M14.0M21.3M22.3M
Operating Income(11.6M)(12.7M)(13.6M)(14.0M)(21.3M)(20.2M)
Ebit(11.6M)(12.7M)(13.6M)(14.0M)(21.3M)(20.2M)
Research Development7.9M8.3M8.8M7.8M13.1M13.8M
Ebitda(10.7M)(12.5M)(13.6M)(14.0M)(21.2M)(20.2M)
Total Operating Expenses10.7M12.5M13.6M14.0M21.2M22.3M
Income Before Tax(10.6M)(12.3M)(13.6M)(13.6M)(19.3M)(18.4M)
Total Other Income Expense Net975K434K82K353K1.9M2.0M
Net Income(10.6M)(12.3M)(13.6M)(13.7M)(19.4M)(18.4M)
Income Tax Expense80K31K27K28K43K45.2K
Selling General Administrative3.7M4.4M4.9M6.2M8.2M8.6M
Net Income From Continuing Ops(10.6M)(12.3M)(13.6M)(13.7M)(18.0M)(17.1M)
Net Income Applicable To Common Shares(5.7M)(10.6M)(12.3M)(13.6M)(12.2M)(11.6M)
Tax Provision80K31K27K28K32.2K33.6K

Pair Trading with DiaMedica Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DiaMedica Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against DiaMedica Stock

  0.42SNDL SNDL Inc Buyout TrendPairCorr
The ability to find closely correlated positions to DiaMedica Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DiaMedica Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DiaMedica Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DiaMedica Therapeutics to buy it.
The correlation of DiaMedica Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DiaMedica Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DiaMedica Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DiaMedica Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DiaMedica Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DiaMedica Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Diamedica Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Diamedica Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.
Note that the DiaMedica Therapeutics information on this page should be used as a complementary analysis to other DiaMedica Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for DiaMedica Stock analysis

When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is DiaMedica Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.60)
Return On Assets
(0.30)
Return On Equity
(0.47)
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.